GCLM and colorectal carcinoma: To investigate the clinical implications of our findings, we examined the levels of nuclear GCLM and T17-phosphorylated GCLM in CRC patients from SYSUCC (n = 406; related clinicopathological information is provided in Supplementary Table 1).